Effects of pravastatin in 3260 patients with unstable angina: results from the LIPID study.
BACKGROUND: The LIPID study is a major trial of secondary prevention of coronary-heart-disease events that includes hospital admission with unstable angina (as well as myocardial infarction) as a qualifying event. In this substudy of LIPID, we compared subsequent cardiovascular risks and the effects...
Main Authors: | Tonkin, A, Colquhoun, D, Emberson, J, Hague, W, Keech, A, Lane, G, MacMahon, S, Shaw, J, Simes, R, Thompson, P, White, H, Hunt, D |
---|---|
Format: | Journal article |
Language: | English |
Published: |
2000
|
Similar Items
-
Effect of pravastatin on frequency of fracture in the LIPID study: secondary analysis of a randomised controlled trial. Long-term Intervention with Pravastatin in Ischaemic Disease.
by: Reid, I, et al.
Published: (2001) -
Effect of pravastatin on frequency of fracture in the LIPID study: secondary analysis of a randomised controlled trial
by: Reid, I, et al.
Published: (2001) -
Pravastatin therapy and the risk of stroke.
by: White, H, et al.
Published: (2000) -
Effects of pravastatin on coronary events in 2073 patients with low levels of both low-density lipoprotein cholesterol and high-density lipoprotein cholesterol: results from the LIPID study.
by: Colquhoun, D, et al.
Published: (2004) -
Long-term risk stratification for survivors of acute coronary syndromes. Results from the Long-term Intervention with Pravastatin in Ischemic Disease (LIPID) Study. LIPID Study Investigators.
by: Marschner, I, et al.
Published: (2001)